129 related articles for article (PubMed ID: 34488527)
1. An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critically ill adult patients.
Gatti M; Viaggi B; Rossolini GM; Pea F; Viale P
Expert Rev Anti Infect Ther; 2022 Mar; 20(3):331-352. PubMed ID: 34488527
[TBL] [Abstract][Full Text] [Related]
2. An Evidence-Based Multidisciplinary Approach Focused on Creating Algorithms for Targeted Therapy of Infection-Related Ventilator-Associated Complications (IVACs) Caused by
Gatti M; Viaggi B; Rossolini GM; Pea F; Viale P
Antibiotics (Basel); 2021 Dec; 11(1):. PubMed ID: 35052910
[TBL] [Abstract][Full Text] [Related]
3. An Evidence-Based Multidisciplinary Approach Focused at Creating Algorithms for Targeted Therapy of BSIs, cUTIs, and cIAIs Caused by
Gatti M; Viaggi B; Rossolini GM; Pea F; Viale P
Infect Drug Resist; 2021; 14():2461-2498. PubMed ID: 34234476
[TBL] [Abstract][Full Text] [Related]
4.
Stewart AG; Cottrell K; Henderson A; Vemuri K; Bauer MJ; Paterson DL; Harris PNA
Microbiol Spectr; 2021 Sep; 9(1):e0022621. PubMed ID: 34232101
[TBL] [Abstract][Full Text] [Related]
5. Detection of Carbapenemase and CTX-M Encoding Genes Directly from Bronchoalveolar Lavage Using the CRE and ESBL ELITe MGB Assays: Toward Early and Optimal Antibiotic Therapy Management of Critically Ill Patients with Pneumonia.
Boattini M; Bianco G; Iannaccone M; Zanotto E; Sidoti F; Almeida A; De Rosa FG; Cavallo R; Costa C
Microb Drug Resist; 2021 Feb; 27(2):241-246. PubMed ID: 32634044
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Rapid Immunochromatographic Tests for the Direct Detection of Extended Spectrum Beta-Lactamases and Carbapenemases in Enterobacterales Isolated from Positive Blood Cultures.
Keshta AS; Elamin N; Hasan MR; Pérez-López A; Roscoe D; Tang P; Suleiman M
Microbiol Spectr; 2021 Dec; 9(3):e0078521. PubMed ID: 34878297
[TBL] [Abstract][Full Text] [Related]
7. A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011-2020.
Dunne MW; Aronin SI; Yu KC; Watts JA; Gupta V
BMC Infect Dis; 2022 Feb; 22(1):194. PubMed ID: 35227203
[TBL] [Abstract][Full Text] [Related]
8. Targeted Therapy of Severe Infections Caused by
Gatti M; Viaggi B; Rossolini GM; Pea F; Viale P
Microorganisms; 2023 Feb; 11(2):. PubMed ID: 36838359
[TBL] [Abstract][Full Text] [Related]
9. In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018).
Piérard D; Stone GG
BMC Infect Dis; 2021 Jun; 21(1):600. PubMed ID: 34162341
[TBL] [Abstract][Full Text] [Related]
10. Fecal Carriage of Extended-Spectrum β-Lactamase and Carbapenemase-Producing Enterobacterales Strains in Patients with Colorectal Cancer in the Oncology Unit of Amizour Hospital, Algeria: A Prospective Cohort Study.
Touati A; Talbi M; Mairi A; Messis A; Adjebli A; Louardiane M; Lavigne JP
Microb Drug Resist; 2020 Nov; 26(11):1383-1389. PubMed ID: 32181693
[No Abstract] [Full Text] [Related]
11. Piperacillin-tazobactam should be preferred to third-generation cephalosporins to treat wild-type inducible AmpC-producing Enterobacterales in critically ill patients with hospital or ventilator-acquired pneumonia.
Carrié C; Bardonneau G; Petit L; Ouattara A; Gruson D; Pereira B; Biais M
J Crit Care; 2020 Apr; 56():6-11. PubMed ID: 31765910
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
[TBL] [Abstract][Full Text] [Related]
13. Direct β-Lactam Inactivation Method: a New Low-Cost Assay for Rapid Detection of Carbapenemase- or Extended-Spectrum-β-Lactamase-Producing
Bianco G; Boattini M; Iannaccone M; Fossati L; Cavallo R; Costa C
J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31694972
[TBL] [Abstract][Full Text] [Related]
14. Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients.
Zerr DM; Miles-Jay A; Kronman MP; Zhou C; Adler AL; Haaland W; Weissman SJ; Elward A; Newland JG; Zaoutis T; Qin X
Antimicrob Agents Chemother; 2016 Jul; 60(7):4237-43. PubMed ID: 27139486
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.
Hagihara M; Kato H; Sugano T; Okade H; Sato N; Shibata Y; Sakanashi D; Asai N; Koizumi Y; Suematsu H; Yamagishi Y; Mikamo H
Int J Antimicrob Agents; 2021 May; 57(5):106330. PubMed ID: 33789129
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible
Kazmierczak KM; Karlowsky JA; de Jonge BLM; Stone GG; Sahm DF
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0200020. PubMed ID: 33972241
[TBL] [Abstract][Full Text] [Related]
17. The paradoxical in vivo activity of β-lactams against metallo-β-lactamase-producing Enterobacterales is not restricted to carbapenems.
Abdelraouf K; Reyes S; Nicolau DP
J Antimicrob Chemother; 2021 Feb; 76(3):684-691. PubMed ID: 33179050
[TBL] [Abstract][Full Text] [Related]
18.
Cervino I; Gonzalez D; Nastro M; Vega J; Reyes AP; Buriano G; Vay C; Famiglietti A; Rodriguez CH
J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34605763
[TBL] [Abstract][Full Text] [Related]
19. Microbiological Characterization of VNRX-5236, a Broad-Spectrum β-Lactamase Inhibitor for Rescue of the Orally Bioavailable Cephalosporin Ceftibuten as a Carbapenem-Sparing Agent against Strains of
Chatwin CL; Hamrick JC; Trout REL; Myers CL; Cusick SM; Weiss WJ; Pulse ME; Xerri L; Burns CJ; Moeck G; Daigle DM; John K; Uehara T; Pevear DC
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0055221. PubMed ID: 34001510
[TBL] [Abstract][Full Text] [Related]
20. Is Ceftazidime/Avibactam an Option for Serious Infections Due to Extended-Spectrum-β-Lactamase- and AmpC-Producing
Isler B; Ezure Y; Romero JLG; Harris P; Stewart AG; Paterson DL
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
